Clinical Trials Browser

NIH × Gemcitabine × Other solid neoplasm × Clear all

NCT04491942 2026-03-18

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Phase 1 Active not recruiting

BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

NCT00027703 2014-02-11

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00024271 2014-01-06

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00005996 2013-12-19

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00243100 2013-12-16

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00020644 2013-08-07

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004090 2013-07-10

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00072228 2013-07-10

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00072436 2013-07-02

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00047047 2013-06-04

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00007917 2013-02-28

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004242 2013-02-11

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005577 2013-02-05

Gemcitabine in Treating Children With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00079352 2013-01-25

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00078962 2013-01-24

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004063 2009-04-30

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

Phase 1/2 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00043095 2008-07-24

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific